BRCA1 deficiency is a recurrent event in early-onset triple-negative breast cancer: a comprehensive analysis of germline mutations and somatic promoter methylation (English)
- New search for: Brianese, R. C.
- New search for: Nakamura, K. D.
- New search for: Almeida, F. G.
- New search for: Ramalho, R. F.
- New search for: Barros, B. D.
- New search for: Ferreira, E. N.
- New search for: Formiga, M. N.
- New search for: Andrade, V. P.
- New search for: Lima, V. C.
- New search for: Carraro, D. M.
- New search for: Brianese, R. C.
- New search for: Nakamura, K. D.
- New search for: Almeida, F. G.
- New search for: Ramalho, R. F.
- New search for: Barros, B. D.
- New search for: Ferreira, E. N.
- New search for: Formiga, M. N.
- New search for: Andrade, V. P.
- New search for: Lima, V. C.
- New search for: Carraro, D. M.
In:
BREAST CANCER RESEARCH AND TREATMENT
;
167
, 3
;
803-814
;
2018
-
ISSN:
- Article (Journal) / Print
-
Title:BRCA1 deficiency is a recurrent event in early-onset triple-negative breast cancer: a comprehensive analysis of germline mutations and somatic promoter methylation
-
Contributors:Brianese, R. C. ( author ) / Nakamura, K. D. ( author ) / Almeida, F. G. ( author ) / Ramalho, R. F. ( author ) / Barros, B. D. ( author ) / Ferreira, E. N. ( author ) / Formiga, M. N. ( author ) / Andrade, V. P. ( author ) / Lima, V. C. ( author ) / Carraro, D. M. ( author )
-
Published in:BREAST CANCER RESEARCH AND TREATMENT ; 167, 3 ; 803-814
-
Publisher:
- New search for: Springer Science + Business Media
-
Place of publication:Springer Science + Business Media
-
Publication date:2018-01-01
-
Size:12 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616.99449
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 616.99449 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 167, Issue 3
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 607
-
Efficacy and safety in older patient subsets in studies of endocrine monotherapy versus combination therapy in patients with HR+/HER2− advanced breast cancer: a reviewFreedman, R. A. / Tolaney, S. M. et al. | 2018
- 615
-
Patient-reported factors associated with adherence to adjuvant endocrine therapy after breast cancer: an integrative reviewLambert, L. K. / Balneaves, L. G. / Howard, A. F. / Gotay, C. C. et al. | 2018
- 635
-
Canine invasive mammary carcinomas as models of human breast cancer. Part 1: natural history and prognostic factorsNguyen, F. d. / Peña, L. / Ibisch, C. / Loussouarn, D. / Gama, A. / Rieder, N. / Belousov, A. / Campone, M. / Abadie, J. r. et al. | 2018
- 649
-
CD56+ immune cell infiltration and MICA are decreased in breast lobules with fibrocystic changesKerekes, D. / Visscher, D. W. / Hoskin, T. L. / Radisky, D. C. / Brahmbhatt, R. D. / Pena, A. / Frost, M. H. / Arshad, M. / Stallings-Mann, M. / Winham, S. J. et al. | 2018
- 659
-
Ribociclib with letrozole vs letrozole alone in elderly patients with hormone receptor-positive, HER2-negative breast cancer in the randomized MONALEESA-2 trialSonke, G. S. / Hart, L. L. / Campone, M. / Erdkamp, F. / Janni, W. / Verma, S. / Villanueva, C. / Jakobsen, E. / Alba, E. / Wist, E. et al. | 2018
- 671
-
Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor studyDirix, L. Y. / Takacs, I. / Jerusalem, G. / Nikolinakos, P. / Arkenau, H. T. / Forero-Torres, A. / Boccia, R. / Lippman, M. E. / Somer, R. / Smakal, M. et al. | 2018
- 687
-
Sensation of the autologous reconstructed breast improves quality of life: a pilot studyCornelissen, A. J. / Beugels, J. / Kuijk, S. M. / Heuts, E. M. / Rozen, S. M. / Spiegel, A. J. / Hulst, R. R. / Tuinder, S. M. et al. | 2018
- 697
-
The yield of targeted genotyping for the recurring mutations in BRCA1/2 in IsraelBernstein-Molho, R. / Laitman, Y. / Schayek, H. / Reish, O. / Lotan, S. / Haim, S. / Zidan, J. / Friedman, E. et al. | 2018
- 703
-
The value of embedding: integrated palliative care for patients with metastatic breast cancerRabow, M. / Small, R. / Jow, A. / Majure, M. / Chien, A. / Melisko, M. / Belkora, J. / Esserman, L. J. / Rugo, H. et al. | 2018
- 709
-
Randomized placebo-controlled pilot trial of omega 3 fatty acids for prevention of aromatase inhibitor-induced musculoskeletal painLustberg, M. B. / Orchard, T. S. / Reinbolt, R. / Andridge, R. / Pan, X. / Belury, M. / Cole, R. / Logan, A. / Layman, R. / Ramaswamy, B. et al. | 2018
- 719
-
The effect of an aerobic exercise bout 24 h prior to each doxorubicin treatment for breast cancer on markers of cardiotoxicity and treatment symptoms: a RCTKirkham, A. A. / Eves, N. D. / Shave, R. E. / Bland, K. A. / Bovard, J. / Gelmon, K. A. / Virani, S. A. / McKenzie, D. C. / Stöhr, E. J. / Waburton, D. E. et al. | 2018
- 731
-
Low PTEN levels and PIK3CA mutations predict resistance to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2 over-expressing breast cancerRimawi, M. F. / De Angelis, C. / Contreras, A. / Pareja, F. / Geyer, F. C. / Burke, K. A. / Herrera, S. / Wang, T. / Mayer, I. A. / Forero, A. et al. | 2018
- 741
-
The effect of genetic variants on the relationship between statins and breast cancer in postmenopausal women in the Women’s Health Initiative observational studyBock, C. H. / Jay, A. M. / Dyson, G. / Beebe-Dimmer, J. L. / Cote, M. L. / Hou, L. / Howard, B. V. / Desai, P. / Purrington, K. / Prentice, R. et al. | 2018
- 751
-
Clinical risk score to predict likelihood of recurrence after ductal carcinoma in situ treated with breast-conserving surgeryPunglia, R. S. / Jiang, W. / Lipsitz, S. R. / Hughes, M. E. / Schnitt, S. J. / Hassett, M. J. / Nekhlyudov, L. / Achacoso, N. / Edge, S. / Javid, S. H. et al. | 2018
- 761
-
Safety of fertility preservation in breast cancer patients in a register-based matched cohort studyRodriguez-Wallberg, K. A. / Eloranta, S. / Krawiec, K. / Lissmats, A. / Bergh, J. / Liljegren, A. et al. | 2018
- 771
-
Breast cancer-related paraneoplastic neurologic diseaseMurphy, B. L. / Zalewski, N. L. / Degnim, A. C. / McKeon, A. / Flanagan, E. P. / Pittock, S. J. / Habermann, E. B. et al. | 2018
- 779
-
Young age at first pregnancy does protect against early onset breast cancer in BRCA1 and BRCA2 mutation carriersEvans, D. / Harkness, E. / Howel, S. / Woodward, E. / Howell, A. / Lalloo, F. et al. | 2018
- 787
-
Impact of microinvasion on breast cancer mortality in women with ductal carcinoma in situSopik, V. / Sun, P. / Narod, S. A. et al. | 2018
- 797
-
Vitamin D supplementation decreases serum 27-hydroxycholesterol in a pilot breast cancer trialGoing, C. C. / Alexandrova, L. / Lau, K. / Yeh, C. Y. / Feldman, D. / Pitteri, S. J. et al. | 2018
- 803
-
BRCA1 deficiency is a recurrent event in early-onset triple-negative breast cancer: a comprehensive analysis of germline mutations and somatic promoter methylationBrianese, R. C. / Nakamura, K. D. / Almeida, F. G. / Ramalho, R. F. / Barros, B. D. / Ferreira, E. N. / Formiga, M. N. / Andrade, V. P. / Lima, V. C. / Carraro, D. M. et al. | 2018
- 815
-
Duration of trastuzumab in HER2-positive metastatic breast cancer after complete remission: still debatable issue?Altundag, K. et al. | 2018
- 817
-
Hormone receptor-positive invasive lobular and ductal carcinoma of the breast have comparable hormone receptor expression levels both if detected by screening and clinicallyRavaioli, A. / Falcini, F. / Bucchi, L. et al. | 2018
- 819
-
Does the elevation of CAMLs predict metastatic breast cancer patients’ survival?Tan, Q. / Qin, Q. et al. | 2018
- 821
-
Dose adjustment in obese breast cancer patients receiving neoadjuvant chemotherapy might have an impact on survivalAltundag, K. et al. | 2018
- 823
-
Reclassifying HER2-equivocal diseaseSorscher, S. et al. | 2018